Ertugrul Erken

Ertugrul Erken

Auto-generated profile, based on publicly available information

Ertugrul Erken

Department of Nephrology, Faculty of Medicine, Kahramanmaras Sutcu Imam University, Kahramanmaras, Turkey

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
OGOzkan Gungor
Ozkan Gungor
HUHilmi Umut Unal
Hilmi Umut Unal
AGAydin Guclu
Aydin Guclu
MGMustafa Gezer
Mustafa Gezer
TETayfun Eyileten
Tayfun Eyileten
MYMahmut Ilker Yilmaz
Mahmut Ilker Yilmaz
Increased inflammation, associated with the increase in chronic kidney disease (CKD) stage, has a very important influence in vascular injury and cardiovascular diseases. In this study, we aimed to investigate the levels of IL-33 and ST2 in the different stages of CKD and to determine their effect on vascular damage and cardiovascular events (CVE). This was an observational cohort study in which serum IL-33 and ST2 were obtained from 238 CKD (stages 1–5) patients. We examined the changes in IL-33/ST2 levels in CKD patients, as well as the association with a surrogate of endothelial dysfunction. Fatal and non-fatal CVE were recorded for a mean of 24 months. We also performed a COX regression analysis to determine the association of IL-33/ST2 levels with CVE and survival. IL-33 and ST2 levels were significantly increased and estimated glomerular filtration rates (eGFR) were decreased. Flow-mediated dilatation (FMD) was significantly decreased from stage 1 to stage 5 CKD. IL-33 and ST2 levels were associated with FMD, and ST2 was a predictor. Multivariate Cox analysis showed that the presence of diabetes mellitus, smoking, and proteinuria and haemoglobin, Hs-CRP, IL-33, and ST2 were associated with the risk of CVE. Kaplan-Meier survival curves showed that patients with IL-33 and ST2 levels below the median value (IL-33 = 132.6 ng/L, ST2 = 382.9 pg/mL) had a higher cumulative survival compared with patients who had IL-33 and ST2 levels above the median value (log-rank test, p = 0.000). This is the first study that demonstrates that serum IL-33 and ST2 are associated with vascular injury, cardiovascular events, and survival in CKD patients.

7 February 2007 in International Journal of Immunogenetics
Verified
Journal Article
Closed access
PDF file
RGR. Gunesacar
R. Gunesacar
EEE. Erken
E. Erken
BBB. Bozkurt
B. Bozkurt
HOH. T. Ozer
H. T. Ozer
SDS. Dinkci
S. Dinkci
ZOZ. Ozbalkan
Z. Ozbalkan

6 August 2016 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
EEErtugrul Erken
Ertugrul Erken
RORuya Ozelsancak
Ruya Ozelsancak
ŞŞŞafak ŞAHİN
Şafak ŞAHİN
EYEmine Ece Yılmaz
Emine Ece Yılmaz
DTDilek Torun
Dilek Torun
SSSiren Sezer
Siren Sezer

1 October 2018 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
OAOrcun Altunoren
Orcun Altunoren
GAGulsum Akkus
Gulsum Akkus
DSDidem Tutuncu Sezal
Didem Tutuncu Sezal
MCMuhammed Ciftcioglu
Muhammed Ciftcioglu
FGFatma Betul Guzel
Fatma Betul Guzel
OGOzkan Gungor
Ozkan Gungor

20 October 2017 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
EEEren Erken
Eren Erken
EEErtugrul Erken
Ertugrul Erken

24 September 2018 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
NENecmi Eren
Necmi Eren
OGOzkan Gungor
Ozkan Gungor
IKIsmail Kocyigit
Ismail Kocyigit
FGFatma Betul Guzel
Fatma Betul Guzel
EEErtugrul Erken
Ertugrul Erken
ATAydin Turkmen
Aydin Turkmen